about
Complete genome sequence of the cystic fibrosis pathogen Achromobacter xylosoxidans NH44784-1996 complies with important pathogenic phenotypesTowards diagnostic guidelines for biofilm-associated infectionsPathogenesis and treatment concepts of orthopaedic biofilm infectionsGarlic blocks quorum sensing and promotes rapid clearing of pulmonary Pseudomonas aeruginosa infectionsCardiobacterium hominis and Cardiobacterium valvarum: Two Case Stories with Infective Episodes in Pacemaker Treated PatientsNitrous oxide production in sputum from cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infectionPolymorphonuclear leukocytes restrict growth of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients.Physiological levels of nitrate support anoxic growth by denitrification of Pseudomonas aeruginosa at growth rates reported in cystic fibrosis lungs and sputum.Reinforcement of the bactericidal effect of ciprofloxacin on Pseudomonas aeruginosa biofilm by hyperbaric oxygen treatment.Biofilms in chronic infections - a matter of opportunity - monospecies biofilms in multispecies infections.The clinical impact of bacterial biofilms.Detection of microbial diversity in endocarditis using cultivation-independent molecular techniques.Lipocalin 2 is protective against E. coli pneumonia.Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth.Ajoene, a sulfur-rich molecule from garlic, inhibits genes controlled by quorum sensing.The interaction pattern of murine serum ficolin-A with microorganismsDietzia papillomatosis bacteremia.Inactivation of the rhlA gene in Pseudomonas aeruginosa prevents rhamnolipid production, disabling the protection against polymorphonuclear leukocytes.Culture-dependent and -independent investigations of microbial diversity on urinary catheters.Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa.Antibiotic penetration and bacterial killing in a Pseudomonas aeruginosa biofilm model.Unexpected Diagnosis of Cerebral Toxoplasmosis by 16S and D2 Large-Subunit Ribosomal DNA PCR and Sequencing.Diffusion Retardation by Binding of Tobramycin in an Alginate Biofilm ModelComparison of two commercial broad-range PCR and sequencing assays for identification of bacteria in culture-negative clinical samplesDirect sequencing and RipSeq interpretation as a tool for identification of polymicrobial infectionsInfective Arthritis: Bacterial 23S rRNA Gene Sequencing as a Supplementary Diagnostic Method.Use of cultivation-dependent and -independent techniques to assess contamination of central venous catheters: a pilot study.Early warning and prevention of pneumonia in acute leukemia by patient education, spirometry, and positive expiratory pressure: A randomized controlled trial.Novel experimental Pseudomonas aeruginosa lung infection model mimicking long-term host-pathogen interactions in cystic fibrosis.The immune system vs. Pseudomonas aeruginosa biofilms.Partial oral treatment of endocarditis.The in vivo biofilm.Strategies for combating bacterial biofilm infections.A review of forty five open tibial fractures covered with free flaps. Analysis of complications, microbiology and prognostic factors.CIED infection with either pocket or systemic infection presentation--complete device removal and long-term antibiotic treatment; long-term outcome.Catheter-Related Bloodstream Infections in Adults Receiving Home Parenteral Nutrition.Biofilms and host response - helpful or harmful.Chronic urinary tract infections in patients with spinal cord lesions - biofilm infection with need for long-term antibiotic treatment.Diagnosis of biofilm infections in cystic fibrosis patients.Hyperbaric oxygen sensitizes anoxic Pseudomonas aeruginosa biofilm to ciprofloxacin.
P50
Q21132701-490A7E96-A04E-4B31-A563-B152803D20B2Q26862701-F77DDFF9-B42A-46E1-B791-10D6104CD50BQ27021149-B702CC29-0A47-44DC-8A63-6BB586D28698Q28286057-AA866B5C-668E-49FE-9878-830857E808ADQ28818272-754489D3-AC34-4942-A78D-C9F7F5A08089Q30742543-8847EE62-87FA-4F64-B2BB-AD1CDED02F07Q30842136-4ECDF1BE-03B3-4705-B2A1-8E6CBF363EC2Q30868724-77EFDF48-289C-4296-8264-A22FE850FEBFQ31037210-9B66774F-87DC-4179-840B-15AD5C691922Q33625314-FA36DFC5-B209-423D-B042-2D5ABE01E3E9Q33870211-AF3F2912-2051-4CBE-8563-DC83633D4CFCQ34002788-07DD53C7-5116-4B51-BAFD-CD54CEF35296Q34028908-8B970FE5-DF76-4F65-801A-F5F4943700D9Q34167016-B0D7061C-99AD-48DB-BE96-653E44ADC80FQ34252814-5639586D-45AF-4506-82F0-72F028D0580AQ34292911-219136F9-6288-4BB0-90F6-408C337CF171Q34335664-34E144A6-7E9A-4FF4-977C-3ACE14CDF76AQ34381458-12795CB5-D689-496E-A66D-0E5C56BA6D8AQ34422651-E47E4E39-8CD4-446A-9F0E-163BF5B18B79Q34623469-531220AE-9FC1-4B3E-ACD6-D7D6B0979B95Q35580712-10C116FD-9A95-422D-A564-BAFE392EEC1AQ35607460-A22690F0-1EF4-4E1A-8761-B0C95A31B812Q35996038-5D56744B-C2A9-4419-BFC9-B22F9523AFE3Q36324308-E9C59562-551C-4DDC-8846-2D4F5083EB8EQ36884385-43CA358C-A083-4712-819E-80E6741B9825Q36993858-916798DB-6AE0-4499-B73D-FA96D9C5B016Q37020265-713144F5-4033-41BE-8911-B83A8F2525BFQ37345664-4DB1080B-F1C5-4A6C-9B33-8997F5A408C7Q37413900-7B22D249-38B7-4AFD-BC66-3B8E58E880CEQ37767747-C1516697-4CDA-4C0C-B31A-EA80128C00A4Q38076849-F0BAD16A-9578-4A84-BC80-CD608A8C4EF4Q38119280-5F330BA0-2662-4887-A242-3EDC58D8D392Q38287542-2B6C737F-4A92-4ECD-BB82-E66CF711DF77Q38370220-86A40733-5FF2-4808-808E-3E31429C2C46Q38612277-9B8D17A9-B5E2-4F42-827B-A1879FECF342Q39024338-CCF9513C-4C8E-45C6-8CA0-705A1BD8B90DQ39240791-E12F5C42-AA8B-405D-97D0-9B73F6892CB0Q39240801-89A25E32-D29C-4A89-BB22-C28D0E26C50CQ39240814-B9A50C6A-5428-4A50-A155-5B7CC35B998FQ40065973-4AFE7216-4B6B-470B-8C19-8FD1538B2828
P50
description
researcher ORCID ID = 0000-0002-7664-8570
@en
wetenschapper
@nl
name
Claus E Moser
@ast
Claus E Moser
@en
Claus E Moser
@nl
type
label
Claus E Moser
@ast
Claus E Moser
@en
Claus E Moser
@nl
prefLabel
Claus E Moser
@ast
Claus E Moser
@en
Claus E Moser
@nl
P214
P106
P21
P214
P31
P496
0000-0002-7664-8570
P734
P7859
viaf-173380488